Skip to content

EXOZ EXOZ Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Gevo logo
GevoGEVO
$172K-3.9%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$111K-96.4%
Upexi logo
UpexiUPXI
$7.47M
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$5.5M+120%
XCF Global, Inc. Class A Common Stock logo
XCF Global, Inc. Class A Common StockSAFX
$6.9M

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: EXOZ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's stock issuance proceeds?
EXOZ (EXOZ) reported stock issuance proceeds of $0 in Q4 2025.
How has EXOZ's stock issuance proceeds changed year-over-year?
EXOZ's stock issuance proceeds decreased by 100.0% year-over-year, from $3.63M to $0.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.